How to Choose a Medical Device Distributor in South Africa

How to Choose a Medical Device Distributor in South Africa

Choosing a medical device distributor in South Africa should involve more than comparing sales forecasts, margins and customer networks.

For an international manufacturer, the distributor can become a critical part of the South African regulatory and operational structure. Depending on the arrangement, the local company may import the devices, hold the relevant SAHPRA medical device establishment licence, maintain product information, store stock, distribute products, manage complaints, support recalls and communicate local regulatory issues back to the manufacturer.

That makes distributor selection both a commercial decision and a regulatory due diligence exercise.

Under SAHPRA’s establishment licensing framework, a distributor is the licence category associated with the importation, exportation and distribution of medical devices and IVDs.

Manufacturers should therefore look beyond whether a prospective partner says it is a medical device distributor. The more important questions are whether the company has the appropriate regulatory authority, whether its Quality Management System supports the proposed products and activities, whether its warehouse and logistics structure is suitable, and whether it can actually build and maintain the market.

What should you look for in a medical device distributor?

A good medical device distributor should be regulatorily suitable, operationally capable and commercially capable of developing the market.

A company may have an excellent sales network but weak medical-device regulatory systems. Another may have a valid SAHPRA licence and strong quality documentation but little capacity to develop the manufacturer’s target customers.

The manufacturer should therefore evaluate the complete operating model rather than selecting a partner only because it satisfies one requirement.

Start by defining the distributor’s role

Before assessing potential distributors, define what the South African partner will actually be expected to do.

This may include importing, customs clearance, warehousing, direct sales, public-sector procurement, clinical support, complaints, recalls, regulatory maintenance and market development.

The preferred distributor should be selected against the actual operating model rather than a generic distributor profile.

For the wider market-entry structure, see How Foreign Medical Device and IVD Manufacturers Can Enter the South African Market.

Verify the SAHPRA establishment licence

The first regulatory check is whether the prospective distributor holds the appropriate SAHPRA medical device establishment licence.

Request the licence and verify the legal entity, licence number, licensed site, licence type, validity, activities and device classes.

Do not rely only on statements such as “SAHPRA approved” or “SAHPRA registered”.

The company represented commercially should correspond with the entity operating under the regulatory licence.

Distributor versus wholesaler matters

A distributor licence and wholesaler licence are not interchangeable.

A distributor licence supports importation, exportation and distribution activities.

A wholesaler generally procures medical devices locally from a manufacturer or distributor and does not have independent authority to import devices under the wholesaler licence.

If products will be shipped directly from outside South Africa, confirm that the proposed partner’s regulatory structure supports importation.

See Medical Device Wholesale Licence in South Africa: SAHPRA Requirements.

Check whether the licence scope fits your products

A valid licence does not automatically mean that every proposed product can immediately be imported and supplied.

Review the risk classes and product information associated with the distributor’s regulatory scope.

Determine whether the new portfolio can be accommodated and what regulatory updates will be required before commercial supply.

The distributor should be able to explain who maintains product information and how additions and changes are controlled.

Review the South African product portfolio

Review the distributor’s existing product portfolio to understand its regulatory experience, customer relationships and commercial priorities.

Consider device types, clinical specialities, manufacturers represented, competing products, storage requirements and technical-support obligations.

A distributor may represent competing products successfully, but the manufacturer should understand how its product will be prioritised.

Assess the distributor’s Quality Management System

A distributor should operate an appropriate documented Quality Management System.

Relevant processes can include document control, training, supplier controls, complaints, CAPA, nonconforming products, recalls, internal audits, management review, storage, distribution and change control.

The due diligence process should establish whether those systems actually operate rather than relying solely on the existence of a Quality Manual.

See ISO 13485 in South Africa: Requirements for Medical Device Companies.

Review the Authorised Representative arrangement

The distributor’s SAHPRA licensing structure includes an Authorised Representative.

The manufacturer should understand who performs the role, whether the individual remains active in the organisation, their regulatory experience and how they interact with quality and commercial personnel.

The role should be operational rather than merely a name appearing on the licence documentation.

See SAHPRA Authorised Representative: Requirements and Responsibilities.

Evaluate warehousing and third-party logistics

Ask where the products will physically be stored.

If the distributor outsources storage, confirm the regulatory status of the third-party facility and review the quality agreement.

The assessment should consider receiving, storage, segregation, inventory management, dispatch, returned products, recalls and record availability.

Third-party logistics should form part of distributor due diligence rather than being treated as a separate commercial arrangement.

Assess storage and environmental controls

The distributor should be capable of maintaining the storage conditions defined by the manufacturer.

Depending on the products, assess temperature monitoring, calibration, environmental controls, alarms, excursion handling, physical security and packaging protection.

Storage requirements can be particularly important for IVD reagents, sterile devices and products with defined temperature limitations.

Review traceability and distribution records

The distributor should be able to determine which products were received and which customers received them.

Depending on the device, records may need to capture catalogue numbers, lots, batches, serial numbers, expiry dates, quantities, customers and delivery dates.

The practical test is whether the distributor can quickly identify affected customers if the manufacturer initiates a recall or corrective action.

Check complaint-handling capability

Review how complaints are received, recorded, investigated and communicated to the manufacturer.

Responsibilities and timelines should be defined.

The distributor should have a mechanism for escalating safety-significant issues and ensuring that complaints are not left solely within the sales organisation.

Complaint information should feed into appropriate quality and corrective-action processes.

Assess recall and vigilance readiness

The distributor should be capable of stopping supply, identifying affected customers, quarantining inventory, communicating corrective actions and reconciling returned products.

The manufacturer should understand who will coordinate communication with SAHPRA and how urgent safety information will be exchanged between the parties.

Recall capability should be tested conceptually before a real field action occurs.

Review regulatory change-control processes

New models, product discontinuations, revised labels, manufacturing-site changes and other regulatory changes should pass through formal review before implementation.

The distributor should understand when its South African regulatory information needs to be updated.

Commercial product additions should not automatically result in importation before the regulatory position has been assessed.

Determine access to technical documentation

The manufacturer and distributor should establish how technical documentation will be provided where SAHPRA requires regulatory evidence.

This is particularly important for higher-risk medical devices.

The arrangement should address confidentiality, response timelines, regulatory requests and the division between information held locally and documentation retained by the original manufacturer.

Assess import and customs capability

Where the distributor will act as importer, assess its experience with medical-device customs clearance, tariff classification, commercial invoices, clearing agents and regulatory questions at the border.

A distributor should understand both its commercial role and its regulatory authority to import.

See Medical Device Customs Clearance in South Africa: Documents and Requirements.

Evaluate sales and market-development capability

After regulatory suitability is established, assess commercial capability.

Consider sales resources, clinical-speciality experience, customer relationships, key-account capability, launch planning, customer education, tender experience and marketing capacity.

The distributor should fit the actual market for the product rather than simply have a large general sales organisation.

Review customer and channel coverage

Understand whether the distributor has access to the customer groups relevant to the product.

These might include private hospitals, public hospitals, laboratories, specialists, pharmacies, provincial health departments or other healthcare channels.

Where sub-distributors are used, determine how those parties are selected and controlled.

Assess technical and after-sales support

Some medical devices require installation, training, preventive maintenance, troubleshooting, calibration or repair.

The manufacturer should establish whether these services are performed by the distributor, manufacturer or an outsourced technical provider.

Where activities such as servicing or refurbishment are conducted locally, the regulatory implications should also be assessed.

Review inventory and forecasting capability

The distributor should have appropriate processes for demand forecasting, safety stock, replenishment, expiry control, inventory reconciliation, returns and slow-moving products.

This becomes especially important for products with limited shelf life, diagnostic reagents or long international manufacturing lead times.

The manufacturer should understand how often forecasts are reviewed and how inventory risks are communicated.

Evaluate reporting and distributor KPIs

Distributor performance should be measurable.

Reporting can address sales, inventory, forecast accuracy, customer acquisition, complaints, returns, regulatory changes, tender activity and market intelligence.

The objective is to provide the manufacturer with sufficient visibility to manage both commercial performance and supply continuity.

Decide who controls the regulatory relationship

Where the distributor holds the local regulatory position, the manufacturer should protect access to regulatory information associated with its products.

The agreement should address SAHPRA correspondence, product information, regulatory records, changes and transition arrangements if the commercial relationship ends.

A manufacturer should avoid becoming unable to change distributors because all local regulatory knowledge resides exclusively with the incumbent partner.

Review the distribution agreement carefully

The distribution agreement should address commercial and regulatory responsibilities consistently.

Relevant areas include territory, products, importation, licensing, quality responsibilities, technical documentation, complaints, recalls, storage, traceability, forecasting, targets, marketing, technical support, audits, subcontracting and termination.

Where a separate quality agreement is used, the two agreements should not contradict one another.

Be cautious with exclusivity

Exclusivity can be commercially appropriate where the distributor is making significant investments in market entry.

However, exclusivity should ideally be connected to measurable performance expectations.

These can include minimum purchases, launch milestones, staffing, market-development activities, reporting, geographic coverage and continued regulatory compliance.

The manufacturer should also plan how the regulatory and operational transition would work if the agreement ends.

Common distributor due diligence mistakes

Common mistakes include selecting a distributor primarily for sales reach, failing to review the actual SAHPRA licence and confusing a wholesaler with an importer-distributor.

Other weaknesses include inadequate review of the QMS, Authorised Representative, outsourced warehousing, complaints, recalls, technical-document access and regulatory change control.

Manufacturers can also create commercial risk by granting exclusivity before measurable performance expectations have been agreed.

Distributor selection should be treated as a formal qualification process.

A practical distributor due diligence checklist

  • Confirm the legal entity.
  • Review the SAHPRA establishment licence.
  • Confirm that importation is authorised where required.
  • Check licence validity and product classes.
  • Assess the proposed product-list pathway.
  • Review the Quality Management System.
  • Identify the Authorised Representative.
  • Confirm the storage location.
  • Assess any third-party warehouse.
  • Review environmental controls.
  • Evaluate traceability.
  • Review complaint handling.
  • Assess recall readiness.
  • Review regulatory change control.
  • Confirm access to technical documentation.
  • Assess customs and import capability.
  • Evaluate customer coverage and relevant market experience.
  • Assess technical and after-sales capability.
  • Review inventory and forecasting systems.
  • Identify competing products.
  • Agree measurable KPIs.
  • Define regulatory responsibilities contractually.
  • Include appropriate audit rights.
  • Control subcontracting.
  • Review exclusivity carefully.
  • Establish a transition plan.

Key regulatory references

  • Medicines and Related Substances Act 101 of 1965, as amended
  • Regulations Relating to Medical Devices and In Vitro Diagnostic Medical Devices
  • SAHPGL-MD-06, Guideline for a Licence to Manufacture, Import, Export or Distribute Medical Devices and IVDs, Version 3
  • SAHPGL-MD-07, Guideline on Questions and Answers: Licensing of Medical Device Establishments, Version 3
  • SAHPGL-MD-05, Guideline on Medical Device Quality Manual, Version 4
  • SAHPGL-MD-04, Guideline for Classification of Medical Devices and IVDs, Version 4
  • Government Notice 4406 of 23 February 2024 relating to Class A medical devices and IVDs
  • Applicable SAHPRA medical-device vigilance and recall requirements

How Verion Medical supports medical device distributor selection

Verion Medical supports international and South African medical device companies in evaluating the regulatory and operational structure needed for distribution in South Africa.

Our market development services can support market-entry planning, distributor strategy and assessment of potential routes to market.

Where a prospective partner’s regulatory position needs to be reviewed, our medical device regulatory affairs services can support licence, portfolio and regulatory due diligence.

Our SAHPRA establishment licensing services can support companies that need to establish or restructure a manufacturer, distributor or wholesaler licensing model, while our ISO 13485 and Quality Management Systems services can support evaluation and development of the quality processes underpinning distribution.

For manufacturers planning the physical movement of products into the country, our import and export services can support regulatory and shipment readiness.

The objective is to select a distributor that can do more than sell the product. The distributor should be capable of supporting compliant importation, controlled distribution, regulatory communication, product traceability and sustainable market development.

If your organisation is assessing potential distributors or developing a South African distribution model, contact Verion Medical for a regulatory and market-entry due diligence assessment.